Merck Life Science: Make or Break Drug Discovery and Biopharma

August 2015. August 2015 / updated November 2015. Andrew Bulpin, Global Head of Merck Millipore Process Solutions, plays a major role in the new Life Science Division In the exclusive interview with B2Bioworld he talks about changes in cell culture media demand, shifts in needs of biopharma customers (e.g. biosimilars versus generics in emerging markets in Asia), as well as ongoing transformation of organisational forms (e.g. in orphan drug manufacturing in Europe).

Includes competitive ranking of Merck Life Science DivisionReading time: 12 min

Read Now:
1,00 EUR (incl. 7% VAT)

Back to section